<DOC>
	<DOCNO>NCT00726115</DOCNO>
	<brief_summary>The main objective study assess safety tolerability ascend single multiple oral dos SAM-531 healthy subject</brief_summary>
	<brief_title>Study Evaluating Safety , Tolerability Pharmacokinetics Single Multiple Dose SAM-531</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Inclusion criterion : Body mass index range 18 30 kg/m2 body weight great equal 50 kg . Body weight elderly subject must great equal 45 kg . history , physical examination finding , clinical laboratory test result , vital sign measurement , digital 12lead ECG reading . Exclusion criterion : Presence history disorder may prevent successful completion study . Any significant cardiovascular , hepatic , renal , respiratory , gastrointestinal ( GI ) , endocrine , immunologic , dermatologic , hematologic , neurologic psychiatric disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2009</verification_date>
</DOC>